Read + Share
Amedeo Smart
Independent Medical Education
Graham DY, Lu H, Shiotani A. Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance. J Gastroenterol Hepatol 2020 Sep 12. doi: 10.1111/jgh.15252.PMID: 32918832
Email
LinkedIn
Facebook
Twitter
Privacy Policy